Spatial Transcriptomics was acquired by 10x Genomics.
Spatial Transcriptomics, a Stockholm, Sweden-based pioneer in the emerging field of spatial genomics, announced that it was acquired by the American 10x Genomics.
Financial details were not disclosed.
10x Genomics will continue to operate Spatial Transcriptomics out of their existing offices in Stockholm, with plans to grow their presence in the heart of Sweden's scientific community. The current team will remain a part of the company and will continue to collaborate with the 10x Genomics team.
Spatial Transcriptomics, founded by Jonas Frisén, Joakim Lundeberg and Patrik Ståhl and led by CEO Anders Haegerstrand, offers technology that allows RNA sequencing to perform in 2D.
The technology originally developed at Science for Life Laboratory in Stockholm, Sweden, as a joint project between two of Sweden’s leading universities, Karolinska Institutet and the Royal Institute of Technology (KTH). Customers include large pharmaceutical companies, as well as universities.